EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
×
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
NYSE:USPH

U.S. Physical Therapy - USPH Stock Forecast, Price & News

$84.87
+2.09 (+2.52%)
(As of 11/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$82.76
$85.45
50-Day Range
$74.54
$91.18
52-Week Range
$73.30
$131.50
Volume
32,448 shs
Average Volume
82,164 shs
Market Capitalization
$1.10 billion
P/E Ratio
28.38
Dividend Yield
1.98%
Price Target
$121.50

U.S. Physical Therapy MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
43.2% Upside
$121.50 Price Target
Short Interest
Bearish
5.59% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$827,145 Sold Last Quarter
Proj. Earnings Growth
7.04%
From $2.70 to $2.89 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.39 out of 5 stars

Medical Sector

280th out of 1,038 stocks

Health Services Industry

5th out of 11 stocks

USPH stock logo

About U.S. Physical Therapy (NYSE:USPH) Stock

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Stock News Headlines

Massive Insider Trade At US Physical Therapy
U.S. Physical Therapy Reports Third Quarter 2022 Results
Should You Invest in U.S. Physical Therapy (USPH)?
USPH U.S. Physical Therapy, Inc.
Let IV therapy in Charleston come to you
US Physical Therapy Inc
See More Headlines
Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Company Calendar

Last Earnings
11/04/2021
Ex-Dividend for 9/16 Dividend
8/17/2022
Dividend Payable
9/16/2022
Ex-Dividend for 12/16 Dividend
11/18/2022
Today
11/29/2022
Dividend Payable
12/16/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
90337L10
Employees
5,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$121.50
High Stock Price Forecast
$123.00
Low Stock Price Forecast
$120.00
Forecasted Upside/Downside
+43.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$40.83 million
Pretax Margin
12.81%

Debt

Sales & Book Value

Annual Sales
$495.02 million
Cash Flow
$4.81 per share
Book Value
$23.02 per share

Miscellaneous

Free Float
12,755,000
Market Cap
$1.10 billion
Optionable
Optionable
Beta
1.31

Key Executives

  • Mr. Christopher J. ReadingMr. Christopher J. Reading (Age 58)
    Pres, CEO & Director
    Comp: $2.02M
  • Mr. Carey P. Hendrickson (Age 60)
    Chief Financial Officer
    Comp: $902.32k
  • Mr. Graham D. Reeve M.B.A.Mr. Graham D. Reeve M.B.A. (Age 58)
    P.T., Chief Operating Officer - West
    Comp: $1.28M
  • Mr. Eric Joseph Williams (Age 56)
    Chief Operating Officer - East
    Comp: $648.2k
  • Mr. Jake Martinez (Age 43)
    Sr. VP of Fin. & Accounting
  • Mr. Chadd Pence
    Sr. VP of Information Systems
  • Mr. Richard S. Binstein (Age 61)
    Exec. VP, Gen. Counsel & Sec.
  • Ms. Jayne Fleck Pool ATC
    PT, SCS, Sr. VP & Chief Compliance Officer
  • Mr. Jason Anderson
    VP of HR
  • Mr. Jon C. Bates (Age 52)
    VP & Corp. Controller













USPH Stock - Frequently Asked Questions

Should I buy or sell U.S. Physical Therapy stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" USPH shares.
View USPH analyst ratings
or view top-rated stocks.

What is U.S. Physical Therapy's stock price forecast for 2023?

1 brokers have issued 12 month target prices for U.S. Physical Therapy's stock. Their USPH share price forecasts range from $120.00 to $123.00. On average, they anticipate the company's share price to reach $121.50 in the next twelve months. This suggests a possible upside of 43.2% from the stock's current price.
View analysts price targets for USPH
or view top-rated stocks among Wall Street analysts.

How have USPH shares performed in 2022?

U.S. Physical Therapy's stock was trading at $95.55 at the start of the year. Since then, USPH shares have decreased by 11.2% and is now trading at $84.87.
View the best growth stocks for 2022 here
.

When is U.S. Physical Therapy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our USPH earnings forecast
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its quarterly earnings data on Thursday, November, 4th. The company reported $0.85 EPS for the quarter, topping analysts' consensus estimates of $0.78 by $0.07. The company earned $125.90 million during the quarter, compared to analyst estimates of $124.67 million. U.S. Physical Therapy had a net margin of 7.34% and a trailing twelve-month return on equity of 12.30%. The firm's revenue was up 15.6% on a year-over-year basis. During the same period last year, the firm earned $0.86 EPS.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Wednesday, November 2nd. Investors of record on Monday, November 21st will be paid a dividend of $0.41 per share on Friday, December 16th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.93%. The ex-dividend date of this dividend is Friday, November 18th.
Read our dividend analysis for USPH
.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.64 per share and currently has a dividend yield of 1.98%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 54.85%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, USPH will have a dividend payout ratio of 56.75% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of $2.65-$2.75 for the period, compared to the consensus earnings per share estimate of $2.71. The company issued revenue guidance of -.

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.57%), Kayne Anderson Rudnick Investment Management LLC (11.86%), Vanguard Group Inc. (7.22%), Eaton Vance Management (4.36%), Boston Trust Walden Corp (3.92%) and Copeland Capital Management LLC (3.72%). Insiders that own company stock include Anne Motsenbocker, Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Christopher J Reading, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner, Regg E Swanson and Richard Binstein.
View institutional ownership trends
.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $84.87.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy (NYSE:USPH) has a market capitalization of $1.10 billion and generates $495.02 million in revenue each year. The company earns $40.83 million in net income (profit) each year or $2.99 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

The company employs 5,500 workers across the globe.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The official website for the company is www.usph.com. The company can be reached via phone at (713) 297-7000, via email at lmcafee@usph.com, or via fax at 713-297-7090.

This page (NYSE:USPH) was last updated on 11/29/2022 by MarketBeat.com Staff